Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2025 Results on July 17

Elevance Health (NYSE: ELV) will release second quarter 2025 financial results on July 17, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

  • 888-947-9963 - Access Code - 3972058 (Domestic)
  • 312-470-0178 - Access Code - 3972058 (International)
  • 866-511-1890 - No Access Code (Domestic Replay)
  • 203-369-1945 - No Access Code (International Replay)

The replay will be available from 11:30 a.m. EDT on July 17, 2025, until the end of the day on August 15, 2025. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. You may also access the webcast here. A webcast replay will be available following the call.

About Elevance Health

Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health’s companies serve over 110 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.74
+0.86 (0.37%)
AAPL  284.36
+1.26 (0.45%)
AMD  222.09
+2.33 (1.06%)
BAC  53.40
+0.16 (0.30%)
GOOG  316.37
+1.25 (0.40%)
META  642.21
+1.34 (0.21%)
MSFT  490.09
+3.35 (0.69%)
NVDA  183.15
+3.23 (1.79%)
ORCL  207.24
+6.30 (3.14%)
TSLA  430.28
+0.14 (0.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.